Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lord

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Cell Reports|April 27, 2017
NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the BrainJose A Matta, Shenyan Gu, Weston B Davini, et al.
Neuron|February 16, 2016
Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHOShenyan Gu, Jose A Matta, Brian Lord, et al.
Journal of Neurochemistry|May 21, 2024
Characterization of tritiated JNJ-GluN2B-5 (3-[<sup>3</sup>H] 1-(azetidin-1-yl)-2-(6-(4-fluoro-3-methyl-phenyl)pyrrolo[3,2-b]pyridin-1-yl)ethanone), a high affinity GluN2B radioligand with selectivity over sigma receptorsJeffrey Schoellerman, Brian Lord, Anindya Bhattacharya, et al.
Plos One|June 10, 2016
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure ModelsWolfgang Fischer, Heike Franke, Ute Krügel, et al.
Frontiers in Human Neuroscience|June 19, 2024
Transcranial focused ultrasound to the posterior cingulate cortex modulates default mode network and subjective experience: an fMRI pilot studyBrian Lord, Joseph L Sanguinetti, Lisannette Ruiz, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptorPascal Bonaventure, Diane Nepomuceno, Curt Mazur, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2007
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodentsPascal Bonaventure, Lisa Kelly, Leah Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2020
Discovery and SAR studies of 2-alkyl-3-phenyl-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepines as 5-HT<sub>7/2</sub> inhibitors leading to the identification of a clinical candidateCurt A Dvorak, Dale A Rudolph, Diane Nepomuceno, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor AntagonistsBrad M Savall, Duncan Wu, Meri De Angelis, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 ReceptorCurt A Dvorak, Heather Coate, Diane Nepomuceno, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Cell Reports|April 27, 2017
NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the BrainJose A Matta, Shenyan Gu, Weston B Davini, et al.
Neuron|February 16, 2016
Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHOShenyan Gu, Jose A Matta, Brian Lord, et al.
Journal of Neurochemistry|May 21, 2024
Characterization of tritiated JNJ-GluN2B-5 (3-[<sup>3</sup>H] 1-(azetidin-1-yl)-2-(6-(4-fluoro-3-methyl-phenyl)pyrrolo[3,2-b]pyridin-1-yl)ethanone), a high affinity GluN2B radioligand with selectivity over sigma receptorsJeffrey Schoellerman, Brian Lord, Anindya Bhattacharya, et al.
Plos One|June 10, 2016
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure ModelsWolfgang Fischer, Heike Franke, Ute Krügel, et al.
Frontiers in Human Neuroscience|June 19, 2024
Transcranial focused ultrasound to the posterior cingulate cortex modulates default mode network and subjective experience: an fMRI pilot studyBrian Lord, Joseph L Sanguinetti, Lisannette Ruiz, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptorPascal Bonaventure, Diane Nepomuceno, Curt Mazur, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2007
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodentsPascal Bonaventure, Lisa Kelly, Leah Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2020
Discovery and SAR studies of 2-alkyl-3-phenyl-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepines as 5-HT<sub>7/2</sub> inhibitors leading to the identification of a clinical candidateCurt A Dvorak, Dale A Rudolph, Diane Nepomuceno, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor AntagonistsBrad M Savall, Duncan Wu, Meri De Angelis, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 ReceptorCurt A Dvorak, Heather Coate, Diane Nepomuceno, et al.
Pageof 7